This is a Phase 2 platform trial registration with no results reported; it describes a planned interventional study in early-stage disease with a surrogate endpoint (tau PET), appropriate for preliminary classification.
Reported
Estimated enrollment450
Primary outcome measureReduction of brain tau deposition as measur…
Study phasePhase 2